Allogene Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $125.6M | $1.05B | $173.3M |
| FY2022 | $112.8M | $978.1M | $84.5M |
| FY2023 | $158.1M | $750.1M | $109.9M |
| FY2024 | $126.5M | $548.7M | $75.2M |
| FY2025 | $123.4M | $415.9M | $51.7M |